HANGZHOU, China, March 6, 2026 /PRNewswire/ — Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for ...

Run a prompt injection attack against Claude Opus 4.6 in a constrained coding environment, and it fails every time, 0% success rate across 200 attempts, no safeguards needed. Move that same attack to ...

Ahead of this week's Opening Ceremony at the Winter Olympics in Milan, the World Anti-Doping Agency has addressed claims originating from a German tabloid that male skiers could be injecting ...

Attorney General Pam Bondi’s demand that Minnesota hand over sensitive voter registration records to the federal government amid tensions over ICE and immigration enforcement underscores the ...

LOUISVILLE, Ky. (WDRB) -- The story of a Louisville woman denied cancer medication was a key part of testimony before the U.S. House Ways and Means Committee on Thursday. Some of the nation's top ...

You know the drill by now. You're sitting in the purgatory of the service center waiting room. Precisely 63 minutes into your wait, the service adviser walks out with a clipboard and calls your name — ...

(RTTNews) - AbbVie (ABBV) announced that a new 6-month 45mg LUPRON DEPOT, or leuprolide acetate for extended-release injectable suspension, strength has received Health Canada approval for the ...

LUPRON DEPOT (leuprolide acetate for extended-release injectable suspension) is a hormonal medication first approved by Health Canada in 1989 for advanced prostate cancer, and later for various ...

A federal judge ruled on Friday that the Trump administration violated the First Amendment by sending automated emails and messages blaming the government shutdown on Democrats. In the ruling, U.S.

“The escalating public health issue of antimicrobial resistance and emergence of highly resistant organisms demands immediate attention and innovative therapeutic solutions. The approval of CONTEPO is ...

A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...